The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Radha Pharmaceuticals Inc., a minority-owned and small disadvantaged business, to provide various strengths and bottle configurations of hydralazine tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service.
The $11,999,990.25 IDC has a base year period of performance from April 8, 2021 to April 7, 2022, with four one-year option periods, for a total potential period of performance through April 7, 2026. The contract utilizes firm-fixed pricing and aims to leverage the VA and DoD Pharmaceutical Prime Vendor programs to efficiently distribute these high-volume pharmaceutical products to government medical facilities. No set-asides were applied, and the contract was awarded under full and open competition following a pre-solicitation notice and subsequent Request for Proposal.
Generated 3/7/25, 9:52 AM